A Blood-Repellent Titanium Surface That Helps Medical Implants Stay Safer and Last Longer

At a Glance

Researchers at Colorado State University have developed a titanium surface that strongly repels blood, helping prevent clot formation on medical devices. This surface uses a combination of nanoscale texture and a fluorinated coating to reduce how blood interacts with implants. By minimizing platelet sticking and activation, this technology improves how implants behave inside the body. It offers a promising approach to making devices like stents and filters safer and more reliable.

Background

Titanium is widely used in medical implants because it is compatible with human tissue, but its interaction with blood can lead to clot formation and device failure. Traditional strategies have focused on creating superhydrophobic surfaces that repel water, but blood behaves differently due to its lower surface tension. As a result, surfaces that repel water do not always effectively repel blood. Developing surfaces that specifically reduce blood adhesion and clotting remains an important challenge in improving implant safety and longevity.

Overview

This technology introduces a superhemophobic titanium surface, meaning it is specifically engineered to repel blood rather than just water. The surface is fabricated by creating nanoscale structures, such as nanotube or nanoflower arrays, on titanium and then applying a fluorinated coating. This combination of surface chemistry and texture reduces the ability of blood components to adhere, spread, and activate on the material.

Unlike conventional superhydrophobic surfaces, which are optimized for liquids with higher surface tension like water, this approach accounts for the unique properties of blood. The engineered surface demonstrates very low interaction with blood, leading to significantly reduced platelet adhesion and activation. As a result, clot formation on the surface is negligible compared to untreated titanium, representing a meaningful improvement in hemocompatibility for implantable devices.